Chiusaroli L, Cozzolino C, Cocchio S, Saia M, Giaquinto C, Dona D
Pathogens. 2025; 14(1).
PMID: 39861054
PMC: 11768092.
DOI: 10.3390/pathogens14010093.
Franconi I, Fais R, Giordano C, Tuvo B, Stani C, Tavanti A
J Fungi (Basel). 2025; 11(1).
PMID: 39852459
PMC: 11767175.
DOI: 10.3390/jof11010040.
Vargas-Junior V, Guimaraes A, Caffarena E, Antunes D
ACS Omega. 2025; 9(51):50134-50146.
PMID: 39741832
PMC: 11683625.
DOI: 10.1021/acsomega.4c00158.
Dos Santos A, Branquinha M
J Fungi (Basel). 2024; 10(12).
PMID: 39728376
PMC: 11679870.
DOI: 10.3390/jof10120880.
Stimolo D, Budin M, De Mauro D, Suero E, Gehrke T, Citak M
J Orthop Traumatol. 2024; 25(1):67.
PMID: 39702802
PMC: 11659542.
DOI: 10.1186/s10195-024-00806-x.
A unique presentation of subcutaneous infection: A case report of a diagnostic challenge.
Posso A, Perez-Meza A, Marquez P, Garzon-Chavez D
Med Mycol Case Rep. 2024; 46:100681.
PMID: 39539539
PMC: 11558622.
DOI: 10.1016/j.mmcr.2024.100681.
An Acute Gangrenous Cholecystitis Caused by Candida auris: A Case From a Greek Hospital.
Pouriki S, Agapitou T, Tsagkaraki A, Manthou P, Tsikrikas S, Varvitsioti D
Cureus. 2024; 16(10):e71338.
PMID: 39534840
PMC: 11555125.
DOI: 10.7759/cureus.71338.
Photodynamic inactivation strategies for maximizing antifungal effect against Sporothrix spp. and Candida albicans in an in vitro investigation.
Rocha A, Inada N, da Silva A, Bagnato V, Buzza H
PLoS Negl Trop Dis. 2024; 18(11):e0012637.
PMID: 39531489
PMC: 11594586.
DOI: 10.1371/journal.pntd.0012637.
The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU.
Zhao J, Sun Y, Tang J, Guo K, Wang K, Zhuge J
Respir Res. 2024; 25(1):360.
PMID: 39369191
PMC: 11453054.
DOI: 10.1186/s12931-024-02991-z.
Review and Current Perspectives on DNA Topoisomerase I and II Enzymes of Fungi as Study Models for the Development of New Antifungal Drugs.
Andrade-Pavon D, Gomez-Garcia O, Villa-Tanaca L
J Fungi (Basel). 2024; 10(9).
PMID: 39330389
PMC: 11432948.
DOI: 10.3390/jof10090629.
Metabolic homeostasis in fungal infections from the perspective of pathogens, immune cells, and whole-body systems.
Weerasinghe H, Stolting H, Rose A, Traven A
Microbiol Mol Biol Rev. 2024; 88(3):e0017122.
PMID: 39230301
PMC: 11426019.
DOI: 10.1128/mmbr.00171-22.
Feline gastrointestinal eosinophilic sclerosing fibroplasia associated with Candida albicans.
Almendros A, Giuliano A, Tse M, Barrs V
Vet Med Sci. 2024; 10(5):e70000.
PMID: 39212262
PMC: 11362976.
DOI: 10.1002/vms3.70000.
Inhibition of Development and Metabolism of Dual-Species Biofilms of and () by Organoselenium Compounds.
Calvi G, Cartaxo G, Carretoni Q, da Silva A, de Moraes D, Pradella J
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204183
PMC: 11359205.
DOI: 10.3390/ph17081078.
Saps1-3 Antigens in : Differential Modulation Following Exposure to Soluble Proteins, Mammalian Cells, and Infection in Mice.
Barbosa P, Goncalves D, Ramos L, Mello T, Braga-Silva L, Pinto M
Infect Dis Rep. 2024; 16(4):572-586.
PMID: 39051243
PMC: 11270244.
DOI: 10.3390/idr16040043.
A novel quantitative double antigen sandwich ELISA for detecting total antibodies against Candida albicans enolase 1.
Wang L, He Z, Guo Y, Ran X, Cheng Y, He Z
Eur J Clin Microbiol Infect Dis. 2024; 43(9):1815-1823.
PMID: 39012550
DOI: 10.1007/s10096-024-04899-4.
Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi.
Wang Z, Shao J
Arch Microbiol. 2024; 206(7):293.
PMID: 38850421
DOI: 10.1007/s00203-024-04010-7.
Incidence and Risk Factors for Acid-fast Bacillus/Fungal Culture Positivity in Primary, Conversion, and Revision Hip and Knee Arthroplasty.
Oetojo W, Feffer M, Wesolowski M, Hopkinson W, Brown N
J Am Acad Orthop Surg. 2024; 32(12):e576-e584.
PMID: 38569465
PMC: 11147707.
DOI: 10.5435/JAAOS-D-23-00980.
A dynamic nomogram to predict invasive fungal super-infection during healthcare-associated bacterial infection in intensive care unit patients: an ambispective cohort study in China.
Li P, Li Y, Zhang Y, Zhu S, Pei Y, Zhang Q
Front Cell Infect Microbiol. 2024; 14:1281759.
PMID: 38469345
PMC: 10925706.
DOI: 10.3389/fcimb.2024.1281759.
Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi.
Sun X, Shi Y, Shi D, Tu Y, Liu L
J Fungi (Basel). 2024; 10(2).
PMID: 38392816
PMC: 10890728.
DOI: 10.3390/jof10020144.
Molecular identification and antifungal susceptibility profiles of etiologic agents of oral candidiasis among HIV-positive patients: A multicenter study.
Morovati H, Jokari M, Eslami S, Zomorodian K, Taeri K, Khalaf N
Curr Med Mycol. 2024; 9(2):10-16.
PMID: 38375522
PMC: 10874477.
DOI: 10.18502/CMM.2023.345058.1414.